Chang Nam Kim

Chang Nam Kim

Auto-generated profile, based on publicly available information

Chang Nam Kim

Department of Neurological Surgery, University of California San Francisco, San Francisco, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2022 in Science
Verified
Journal Article
Closed access
EWEthan A. Winkler
Ethan A. Winkler
CKChang N. Kim
Chang N. Kim
JRJayden M. Ross
Jayden M. Ross
JGJoseph H. Garcia
Joseph H. Garcia
EGEugene Gil
Eugene Gil
TNTomasz Jan Nowakowski
Tomasz Jan Nowakowski
Cerebrovascular diseases are a leading cause of death and neurologic disability. Further understanding of disease mechanisms and therapeutic strategies requires a deeper knowledge of cerebrovascular cells in humans. We profiled transcriptomes of 181,388 cells to define a cell atlas of the adult human cerebrovasculature, including endothelial cell molecular signatures with arteriovenous segmentation and expanded perivascular cell diversity. By leveraging this reference, we investigated cellular and molecular perturbations in brain arteriovenous malformations, which are a leading cause of stroke in young people, and identified pathologic endothelial transformations with abnormal vascular patterning and the ontology of vascularly derived inflammation. We illustrate the interplay between vascular and immune cells that contributes to brain hemorrhage and catalog opportunities for targeting angiogenic and inflammatory programs in vascular malformations.

16 September 2021 in Cell Stem Cell
Verified
Journal Article
Closed access
GPGalina Popova
Galina Popova
SSSarah S. Soliman
Sarah S. Soliman
CKChang N. Kim
Chang N. Kim
MKMatthew G. Keefe
Matthew G. Keefe
KHKelsey M. Hennick
Kelsey M. Hennick
TNTomasz Jan Nowakowski
Tomasz Jan Nowakowski

20 November 2024 in Nature Medicine
Verified
Journal Article
Open access
PDF file
SBSam N. Barnett
Sam N. Barnett
ACAna-Maria Cujba
Ana-Maria Cujba
LYLu Yang
Lu Yang
AMAna Raquel Maceiras
Ana Raquel Maceiras
SLShuang Li
Shuang Li
STSarah A. Teichmann
Sarah A. Teichmann
The human vascular system, comprising endothelial cells (ECs) and mural cells, covers a vast surface area in the body, providing a critical interface between blood and tissue environments. Functional differences exist across specific vascular beds, but their molecular determinants across tissues remain largely unknown. In this study, we integrated single-cell transcriptomics data from 19 human organs and tissues and defined 42 vascular cell states from approximately 67,000 cells (62 donors), including angiotypic transitional signatures along the arterial endothelial axis from large to small caliber vessels. We also characterized organotypic populations, including splenic littoral and blood–brain barrier ECs, thus clarifying the molecular profiles of these important cell states. Interrogating endothelial–mural cell molecular crosstalk revealed angiotypic and organotypic communication pathways related to Notch, Wnt, retinoic acid, prostaglandin and cell adhesion signaling. Transcription factor network analysis revealed differential regulation of downstream target genes in tissue-specific modules, such as those of FOXF1 across multiple lung vascular subpopulations. Additionally, we make mechanistic inferences of vascular drug targets within different vascular beds. This open-access resource enhances our understanding of angiodiversity and organotypic molecular signatures in human vascular cells, and has therapeutic implications for vascular diseases across tissues.

11 November 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
TWTianyun Wang
Tianyun Wang
CKChang N Kim
Chang N Kim
TBTrygve E Bakken
Trygve E Bakken
MGMadelyn A Gillentine
Madelyn A Gillentine
BHBarbara Henning
Barbara Henning
FMF. Kumara Eugene Mastrorosa
F. Kumara Eugene Mastrorosa
Most genetic studies consider autism spectrum disorder (ASD) and developmental disorder (DD) separately despite overwhelming comorbidity and shared genetic etiology. Here, we analyzed de novo variants (DNVs) from 15,560 ASD (6,557 from SPARK) and 31,052 DD trios independently and also combined as broader neurodevelopmental disorders (NDDs) using three models. We identify 615 NDD candidate genes (false discovery rate [FDR] < 0.05) supported by ≥1 models, including 138 reaching Bonferroni exome-wide significance ( P < 3.64e–7) in all models. The genes group into five functional networks associating with different brain developmental lineages based on single-cell nuclei transcriptomic data. We find no evidence for ASD-specific genes in contrast to 18 genes significantly enriched for DD. There are 53 genes that show mutational bias, including enrichments for missense ( n = 41) or truncating ( n = 12) DNVs. We also find 10 genes with evidence of male- or female-bias enrichment, including 4 X chromosome genes with significant female burden ( DDX3X , MECP2 , WDR45 , and HDAC8) . This large-scale integrative analysis identifies candidates and functional subsets of NDD genes.

13 October 2023 in Science
Verified
Journal Article
Closed access
CKChang N. Kim
Chang N. Kim
DSDavid Shin
David Shin
AWAlbert Wang
Albert Wang
TNTomasz Jan Nowakowski
Tomasz Jan Nowakowski
The thalamus plays a central coordinating role in the brain. Thalamic neurons are organized into spatially distinct nuclei, but the molecular architecture of thalamic development is poorly understood, especially in humans. To begin to delineate the molecular trajectories of cell fate specification and organization in the developing human thalamus, we used single-cell and multiplexed spatial transcriptomics. We show that molecularly defined thalamic neurons differentiate in the second trimester of human development and that these neurons organize into spatially and molecularly distinct nuclei. We identified major subtypes of glutamatergic neuron subtypes that are differentially enriched in anatomically distinct nuclei and six subtypes of γ-aminobutyric acid–mediated (GABAergic) neurons that are shared and distinct across thalamic nuclei.

4 June 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
MCMireia Coll-Tané
Mireia Coll-Tané
NGNaihua N. Gong
Naihua N. Gong
SBSamuel J. Belfer
Samuel J. Belfer
LRLara V. van Renssen
Lara V. van Renssen
EKEvangeline C. Kurtz-Nelson
Evangeline C. Kurtz-Nelson
ASAnnette Schenck
Annette Schenck
Sleep disturbances in autism and neurodevelopmental disorders are common and adversely affect patient’s quality of life, yet the underlying mechanisms are understudied. We found that individuals with mutations in CHD8, among the highest-confidence autism risk genes, or CHD7 suffer from disturbed sleep maintenance. These defects are recapitulated in Drosophila mutants affecting kismet, the sole CHD8/CHD7 ortholog. We show that Kismet is required in glia for early developmental and adult sleep architecture. This role localizes to subperineurial glia constituting the blood-brain barrier. We demonstrate that Kismet-related sleep disturbances are caused by high serotonin during development, paralleling a well-established but genetically unsolved autism endophenotype. Despite their developmental origin, Kismet’s sleep architecture defects can be reversed in adulthood by a behavioral regime resembling human sleep restriction therapy. Our findings provide fundamental insights into glial regulation of sleep and propose a causal mechanistic link between the CHD8/CHD7/Kismet family, developmental hyperserotonemia, and autism-associated sleep disturbances.